Sofinnova Partners closes €82 million Sofinnova MD Start IV fund

• Sofinnova Partners closed Sofinnova MD Start IV at EUR 82 million, an oversubscribed final close.
• Capital targets medtech venture creation across Europe, the US, with plans to launch six to eight companies over five years.
• Prior MD Start III fund size totaled EUR 63 million, backing six companies that raised more than EUR 140 million in follow-on financing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sofinnova Partners SAS published the original content used to generate this news brief on September 28, 2026, and is solely responsible for the information contained therein.